investorscraft@gmail.com

Intrinsic ValueVisiodent S.A. (SDT.PA)

Previous Close3.00
Intrinsic Value
Upside potential
Previous Close
3.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2020 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Visiodent SA operates in the dental health sector, specializing in cloud-based management software for dental practices and health centers through its Veasy platform. The company serves a global market, leveraging its 1983 founding and subsidiary status under Groupe Visiodent SAS to establish credibility in healthcare IT. Its core revenue model revolves around subscription-based SaaS solutions, enabling dental professionals to streamline administrative and clinical workflows. Visiodent competes in the niche but growing healthcare information services segment, where digitization and efficiency are increasingly prioritized. The company’s market position is bolstered by its long-standing industry presence and focus on dental-specific software, differentiating it from broader healthcare IT providers. While the sector is competitive, Visiodent’s specialized offering and European base provide a stable foothold in a market transitioning toward cloud-based solutions.

Revenue Profitability And Efficiency

In FY 2020, Visiodent reported revenue of €9.09 million, with net income of €644,555, reflecting a net margin of approximately 7.1%. The company generated €1.99 million in operating cash flow, indicating solid cash conversion from operations. Capital expenditures of €1.20 million suggest ongoing investments in its software platform, aligning with its SaaS-focused model.

Earnings Power And Capital Efficiency

The company’s diluted EPS of €0.14 demonstrates modest but positive earnings power. With operating cash flow covering capital expenditures, Visiodent maintains adequate capital efficiency. Its SaaS model likely supports recurring revenue, though further details on customer retention or growth metrics would clarify long-term earnings sustainability.

Balance Sheet And Financial Health

Visiodent’s balance sheet shows €3.07 million in cash and equivalents against €2.61 million in total debt, indicating a manageable leverage position. The net cash position provides liquidity for operations and potential growth initiatives, though the debt level warrants monitoring given the company’s modest scale.

Growth Trends And Dividend Policy

The company paid a dividend of €1.83 per share in FY 2020, a notable distribution relative to its EPS. This suggests a shareholder-friendly policy, though sustainability depends on future profitability. Growth trends are unclear without historical data, but the healthcare IT sector’s expansion could benefit Visiodent’s niche focus.

Valuation And Market Expectations

With no reported market capitalization and a beta of -0.35, Visiodent appears to be a micro-cap stock with low correlation to broader markets. The lack of valuation multiples limits insight, but the dividend yield and SaaS model may attract income and growth investors, respectively.

Strategic Advantages And Outlook

Visiodent’s strategic advantages include its specialized dental software and established industry presence. The shift toward digital healthcare solutions could drive demand for its offerings, though competition and execution risks remain. The outlook hinges on its ability to scale its SaaS platform while maintaining profitability and cash flow.

Sources

Company filings, Euronext Paris

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021202220232024202520262027202820292030203120322033203420352036203720382039204020412042204320442045

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount